Introducing Lapatinib Ditosylate, the generic for Tykerb, Anti‑Breast Cancer Tablet – a tyrosine kinase inhibitor targeting HER2‑positive breast cancer. It interferes with cellular growth signals and tumor proliferation while promoting apoptosis. Experience effective dual blockade of HER2 and EGFR pathways, improved treatment response, and enhanced progression‑free survival with this advanced targeted therapy.